Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
10m
Today's Stocks on Sale: HIMS and More
Bearish investors decided to classify Hims & Hers Health (HIMS) as an obesity drug supplier. HIMS stock lost 9.6% on Thursday after the U.S. Food and Drug Administration said that GLP-1, made by Eli ...
22m
NHS proposes phased launch for Eli Lilly’s Mounjaro
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US port strike ends
Accused of sexual assault
To stay at rescue center
Jan. 6 charges dismissal bid
Wreck of WWII ship found
Nevada politician guilty
Murder case to be reviewed
Plastic-eating bacteria
Processing times drop
Union skips endorsement
Sued over mass layoffs
To be closed indefinitely
CDC flu vaccine report
3 pitching coaches fired
Water fluoridation research
Tropical Storm Leslie forms
Settles overcharging lawsuit
India, US sign minerals pact
First mpox test approved
Free tax filing expansion
Sentenced to 9 yrs in prison
Texas AG sues TikTok
TikTok star charged
Surveys Helene damage
Freed from Gaza captivity
Secures $4 billion credit line
Kirk becomes Category 4
Ex-Memphis cops guilty
Mortgage rate ticks up
Related topics
Food and Drug Administration
Mounjaro
Zepbound
Feedback